$NEWT
NewtekOne, Inc. Stock $newt

$newt Overview Financials Valuation SEC Filings Company Website

2024 Q2 Form 10-Q Financial Statement

#000158798724000082 Filed on May 10, 2024

Income Statement

Concept	2024 Q2	2024 Q1	2023 Q1
Revenue	$63.55M	$59.68M	$42.96M
YoY Change	25.91%	38.92%	20.52%
Cost Of Revenue	$5.693M	$4.846M	$4.504M
YoY Change	17.67%	7.59%
Gross Profit	$57.86M	$54.83M	$38.45M
YoY Change	26.79%	42.59%
Gross Profit Margin	91.04%	91.88%	89.52%
Selling, General & Admin	$30.93M	$32.37M	$30.02M
YoY Change	-0.37%	7.85%	104.95%
% of Gross Profit	53.46%	59.04%	78.06%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$521.0K	$532.0K	$873.0K
YoY Change	-37.38%	-39.06%	1264.06%
% of Gross Profit	0.9%	0.97%	2.27%
Operating Expenses	$34.87M	$36.31M	$34.69M
YoY Change	-1.33%	4.67%	135.86%
Operating Profit	$22.99M	$18.52M	$3.761M
YoY Change	123.33%	392.37%
Interest Expense	-$20.23M	$18.16M	$14.13M
YoY Change	30.43%	28.51%	-236.67%
% of Operating Profit	-87.98%	98.07%	375.75%
Other Income/Expense, Net	$12.02M	$12.74M	$15.72M
YoY Change	-17.45%	-18.94%	-1766.91%
Pretax Income	$14.78M	$13.10M	$6.855M
YoY Change	58.17%	91.09%	-28.98%
Income Tax	$3.838M	$3.449M	-$4.863M
% Of Pretax Income	25.96%	26.33%	-70.94%
Net Earnings	$10.95M	$9.650M	$11.72M
YoY Change	69.61%	-17.65%	21.4%
Net Earnings / Revenue	17.22%	16.17%	27.28%
Basic Earnings Per Share	$0.43	$0.38	$0.46
Diluted Earnings Per Share	$0.43	$0.38	$0.46
COMMON SHARES
Basic Shares Outstanding	24.73M shares	24.71M shares	24.61M shares
Diluted Shares Outstanding	24.71M shares	24.36M shares	25.24M shares

Balance Sheet

Concept	2024 Q2	2024 Q1	2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$234.8M	$191.3M	$230.0M
YoY Change	23.82%	-16.83%	4584.36%
Cash & Equivalents	$206.3M	$163.2M	$197.1M
Short-Term Investments	$28.42M	$28.13M	$32.91M
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$249.4M	$184.3M	$166.0M
YoY Change	-19.39%	11.06%	527.58%
LONG-TERM ASSETS
Property, Plant & Equipment	$5.110M	$5.193M	$7.492M
YoY Change	-27.02%	-30.69%	6.95%
Goodwill	$25.89M	$25.89M	$21.19M
YoY Change	22.49%	22.16%
Intangibles
YoY Change
Long-Term Investments	$754.0M	$767.0M	$592.1M
YoY Change	22.39%	29.55%	15.43%
Other Assets	$38.78M	$38.48M	$80.82M
YoY Change	-45.67%	-52.4%	-49.02%
Total Long-Term Assets	$1.368B	$1.325B	$1.084B
YoY Change	21.06%	22.28%	10.27%
TOTAL ASSETS
Total Short-Term Assets	$249.4M	$184.3M	$166.0M
Total Long-Term Assets	$1.368B	$1.325B	$1.084B
Total Assets	$1.617B	$1.510B	$1.250B
YoY Change	12.36%	20.79%	23.82%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$46.73M	$41.99M	$45.26M
YoY Change	15.37%	-7.23%	280.31%
Accrued Expenses	$6.225M	$6.344M	$9.144M
YoY Change	-27.21%	-30.62%	5.15%
Deferred Revenue
YoY Change
Short-Term Debt	$610.4M	$512.9M	$363.5M
YoY Change	36.45%	41.11%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$691.0M	$593.0M	$446.1M
YoY Change	32.64%	32.92%	221.77%
LONG-TERM LIABILITIES
Long-Term Debt	$652.0M	$662.5M	$581.5M
YoY Change	-6.51%	13.93%	26.81%
Other Long-Term Liabilities			$624.0K
YoY Change
Total Long-Term Liabilities	$652.0M	$662.5M	$582.1M
YoY Change	-6.51%	13.81%	26.95%
TOTAL LIABILITIES
Total Short-Term Liabilities	$691.0M	$593.0M	$446.1M
Total Long-Term Liabilities	$652.0M	$662.5M	$582.1M
Total Liabilities	$1.343B	$1.255B	$1.032B
YoY Change	10.27%	21.69%	68.9%
SHAREHOLDERS EQUITY
Retained Earnings	$38.25M	$32.61M	$7.047M
YoY Change	321.5%	362.76%
Common Stock	$517.0K	$493.0K	$491.0K
YoY Change	5.3%	0.41%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$274.0M	$254.1M	$218.5M
YoY Change
Total Liabilities & Shareholders Equity	$1.617B	$1.510B	$1.250B
YoY Change	12.36%	20.79%	23.82%

Cashflow Statement

Concept	2024 Q2	2024 Q1	2023 Q1
OPERATING ACTIVITIES
Net Income	$10.95M	$9.650M	$11.72M
YoY Change	69.61%	-17.65%	21.4%
Depreciation, Depletion And Amortization	$521.0K	$532.0K	$873.0K
YoY Change	-37.38%	-39.06%	1264.06%
Cash From Operating Activities	$2.923M	-$38.67M	-$116.4M
YoY Change	-103.3%	-66.76%	-1896.22%
INVESTING ACTIVITIES
Capital Expenditures	$71.00K	$57.00K	$165.0K
YoY Change	-297.22%	-65.45%
Acquisitions		$0.00	-$11.25M
YoY Change		-100.0%
Other Investing Activities	-$53.89M	-$43.75M	-$23.73M
YoY Change	10.69%	84.33%
Cash From Investing Activities	-$53.96M	-$43.81M	-$23.90M
YoY Change	10.92%	83.3%
FINANCING ACTIVITIES
Cash Dividend Paid		$4.771M	$0.00
YoY Change			-100.0%
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	94.17M	$61.68M	$186.9M
YoY Change	-52.66%	-67.0%	-725.41%
NET CHANGE
Cash From Operating Activities	2.923M	-$38.67M	-$116.4M
Cash From Investing Activities	-53.96M	-$43.81M	-$23.90M
Cash From Financing Activities	94.17M	$61.68M	$186.9M
Net Change In Cash	43.13M	-$20.80M	$46.64M
YoY Change	-30.18%	-144.6%	-299.27%
FREE CASH FLOW
Cash From Operating Activities	$2.923M	-$38.67M	-$116.4M
Capital Expenditures	$71.00K	$57.00K	$165.0K
Free Cash Flow	$2.852M	-$38.73M	-$116.5M
YoY Change	-103.22%	-66.76%	-1898.77%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	24715000	shares
CY2024Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	24715000	shares
CY2024Q1	us-gaap	Notes Receivable Gross NotesReceivableGross	397625000	usd
CY2023Q4	us-gaap	Notes Receivable Gross NotesReceivableGross	336305000	usd
CY2024Q1	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	16126000	usd
CY2023Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	12574000	usd
CY2024Q1	us-gaap	Notes Receivable Net NotesReceivableNet	381499000	usd
CY2023Q4	us-gaap	Notes Receivable Net NotesReceivableNet	323731000	usd
CY2024Q1	us-gaap	Debt Securities Available For Sale Accrued Interest After Allowance For Credit Loss Statement Of Financial Position Extensible List DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLossStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OtherAssets
CY2024Q1	us-gaap	Derivative Liability Statement Of Financial Position Extensible Enumeration DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration	http://fasb.org/us-gaap/2023#AccountsPayableAndOtherAccruedLiabilities
CY2023Q4	us-gaap	Derivative Liability Statement Of Financial Position Extensible Enumeration DerivativeLiabilityStatementOfFinancialPositionExtensibleEnumeration	http://fasb.org/us-gaap/2023#AccountsPayableAndOtherAccruedLiabilities
CY2024Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	20000	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	20000	shares
CY2024Q1	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	24985000	usd
CY2023Q1	us-gaap	Interest And Fee Income Loans And Leases InterestAndFeeIncomeLoansAndLeases	17502000	usd
CY2024Q1	us-gaap	Interest Income Other InterestIncomeOther	1622000	usd
CY2023Q1	us-gaap	Interest Income Other InterestIncomeOther	981000	usd
CY2024Q1	us-gaap	Interest Income Operating InterestIncomeOperating	27067000	usd
CY2023Q1	us-gaap	Interest Income Operating InterestIncomeOperating	18715000	usd
CY2024Q1	us-gaap	Interest Expense Customer Deposits InterestExpenseCustomerDeposits	5576000	usd
CY2023Q1	us-gaap	Interest Expense Customer Deposits InterestExpenseCustomerDeposits	1475000	usd
CY2024Q1	us-gaap	Interest Expense InterestExpense	18161000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	14132000	usd
CY2024Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	8906000	usd
CY2023Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	4583000	usd
CY2024Q1	us-gaap	Provision For Loan Lease And Other Losses ProvisionForLoanLeaseAndOtherLosses	4015000	usd
CY2023Q1	us-gaap	Provision For Loan Lease And Other Losses ProvisionForLoanLeaseAndOtherLosses	1318000	usd
CY2024Q1	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss	4891000	usd
CY2023Q1	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss	3265000	usd
CY2024Q1	us-gaap	Investment Income Dividend InvestmentIncomeDividend	386000	usd
CY2023Q1	us-gaap	Investment Income Dividend InvestmentIncomeDividend	504000	usd
CY2024Q1	newt	Loan Servicing Asset Revaluation LoanServicingAssetRevaluation	-1735000	usd
CY2023Q1	newt	Loan Servicing Asset Revaluation LoanServicingAssetRevaluation	919000	usd
CY2024Q1	us-gaap	Contractually Specified Servicing Fees Late Fees And Ancillary Fees Earned In Exchange For Servicing Financial Assets ContractuallySpecifiedServicingFeesLateFeesAndAncillaryFeesEarnedInExchangeForServicingFinancialAssets	5357000	usd
CY2023Q1	us-gaap	Contractually Specified Servicing Fees Late Fees And Ancillary Fees Earned In Exchange For Servicing Financial Assets ContractuallySpecifiedServicingFeesLateFeesAndAncillaryFeesEarnedInExchangeForServicingFinancialAssets	4403000	usd
CY2024Q1	us-gaap	Gain Loss On Sales Of Loans Net GainLossOnSalesOfLoansNet	20292000	usd
CY2023Q1	us-gaap	Gain Loss On Sales Of Loans Net GainLossOnSalesOfLoansNet	6367000	usd
CY2024Q1	newt	Unrealized Gain Loss On Sales Of Loans Net Fair Value Option UnrealizedGainLossOnSalesOfLoansNetFairValueOption	2798000	usd
CY2023Q1	newt	Unrealized Gain Loss On Sales Of Loans Net Fair Value Option UnrealizedGainLossOnSalesOfLoansNetFairValueOption	5905000	usd
CY2024Q1	newt	Web Hosting And It Support Income WebHostingAndITSupportIncome	5770000	usd
CY2023Q1	newt	Web Hosting And It Support Income WebHostingAndITSupportIncome	6709000	usd
CY2024Q1	newt	Electronic Payment Processing Income ElectronicPaymentProcessingIncome	10987000	usd
CY2023Q1	newt	Electronic Payment Processing Income ElectronicPaymentProcessingIncome	10328000	usd
CY2024Q1	us-gaap	Noninterest Income Other NoninterestIncomeOther	5512000	usd
CY2023Q1	us-gaap	Noninterest Income Other NoninterestIncomeOther	7221000	usd
CY2024Q1	us-gaap	Noninterest Income NoninterestIncome	49367000	usd
CY2023Q1	us-gaap	Noninterest Income NoninterestIncome	42356000	usd
CY2024Q1	us-gaap	Labor And Related Expense LaborAndRelatedExpense	20506000	usd
CY2023Q1	us-gaap	Labor And Related Expense LaborAndRelatedExpense	19073000	usd
CY2024Q1	us-gaap	Information Technology And Data Processing InformationTechnologyAndDataProcessing	3408000	usd
CY2023Q1	us-gaap	Information Technology And Data Processing InformationTechnologyAndDataProcessing	3803000	usd
CY2024Q1	newt	Electronic Payment Processing Expense ElectronicPaymentProcessingExpense	4846000	usd
CY2023Q1	newt	Electronic Payment Processing Expense ElectronicPaymentProcessingExpense	4504000	usd
CY2024Q1	us-gaap	Professional Fees ProfessionalFees	4565000	usd
CY2023Q1	us-gaap	Professional Fees ProfessionalFees	3440000	usd
CY2024Q1	newt	Loan Processing Fee Other LoanProcessingFeeOther	2244000	usd
CY2023Q1	newt	Loan Processing Fee Other LoanProcessingFeeOther	2781000	usd
CY2024Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	532000	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	791000	usd
CY2024Q1	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	5058000	usd
CY2023Q1	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	4631000	usd
CY2024Q1	us-gaap	Noninterest Expense NoninterestExpense	41159000	usd
CY2023Q1	us-gaap	Noninterest Expense NoninterestExpense	39023000	usd
CY2024Q1	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	13099000	usd
CY2023Q1	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	6598000	usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3449000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-11952000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	9650000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	18550000	usd
CY2024Q1	us-gaap	Dividends Preferred Stock DividendsPreferredStock	400000	usd
CY2023Q1	us-gaap	Dividends Preferred Stock DividendsPreferredStock	249000	usd
CY2024Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	9250000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	18301000	usd
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.38
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.76
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.38
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.74
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	9650000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	18550000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax	9000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax	-113000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Before Tax Portion Attributable To Parent OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent	9000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Before Tax Portion Attributable To Parent OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent	-113000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Tax Portion Attributable To Parent1 OtherComprehensiveIncomeLossTaxPortionAttributableToParent1	2000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Tax Portion Attributable To Parent1 OtherComprehensiveIncomeLossTaxPortionAttributableToParent1	-31000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	7000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-82000	usd
CY2024Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	9657000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	18468000	usd
CY2024Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	681000	usd
CY2024Q1	us-gaap	Dividends Dividends	0	usd
CY2024Q1	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	253000	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	1000	usd
CY2024Q1	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	56000	usd
CY2024Q1	newt	Adjustments To Additional Paid In Capital Amortization Of Stock Offering Costs AdjustmentsToAdditionalPaidInCapitalAmortizationOfStockOfferingCosts	39000	usd
CY2024Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.19
CY2024Q1	us-gaap	Dividends Common Stock DividendsCommonStock	4617000	usd
CY2024Q1	us-gaap	Preferred Stock Dividends Per Share Declared PreferredStockDividendsPerShareDeclared	20.00
CY2024Q1	us-gaap	Dividends Preferred Stock DividendsPreferredStock	400000	usd
CY2024Q1	us-gaap	Profit Loss ProfitLoss	9650000	usd
CY2024Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	7000	usd
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	254132000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	738000	usd
CY2023Q1	us-gaap	Dividends Dividends	0	usd
CY2023Q1	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	429000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	20000000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	507000	usd
CY2023Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.18
CY2023Q1	us-gaap	Dividends Common Stock DividendsCommonStock	4363000	usd
CY2023Q1	us-gaap	Preferred Stock Dividends Per Share Declared PreferredStockDividendsPerShareDeclared	12.27
CY2023Q1	us-gaap	Dividends Preferred Stock DividendsPreferredStock	249000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	18550000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-82000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	232586000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	9650000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	18550000	usd
CY2024Q1	newt	Unrealized Gain Loss On Sales Of Loans Net Fair Value Option UnrealizedGainLossOnSalesOfLoansNetFairValueOption	2798000	usd
CY2023Q1	newt	Unrealized Gain Loss On Sales Of Loans Net Fair Value Option UnrealizedGainLossOnSalesOfLoansNetFairValueOption	5905000	usd
CY2024Q1	newt	Unrealized Gain Loss On Servicing Assets UnrealizedGainLossOnServicingAssets	-1735000	usd
CY2023Q1	newt	Unrealized Gain Loss On Servicing Assets UnrealizedGainLossOnServicingAssets	919000	usd
CY2024Q1	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	592000	usd
CY2023Q1	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	-495000	usd
CY2024Q1	us-gaap	Gain Loss On Sales Of Loans Net GainLossOnSalesOfLoansNet	20292000	usd
CY2023Q1	us-gaap	Gain Loss On Sales Of Loans Net GainLossOnSalesOfLoansNet	6367000	usd
CY2024Q1	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	61000	usd
CY2023Q1	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	0	usd
CY2024Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	987000	usd
CY2023Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1249000	usd
CY2024Q1	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	4015000	usd
CY2023Q1	us-gaap	Provision For Loan Losses Expensed ProvisionForLoanLossesExpensed	-1318000	usd
CY2024Q1	newt	Lower Of Cost Or Market Adjustment LowerOfCostOrMarketAdjustment	-221000	usd
CY2023Q1	newt	Lower Of Cost Or Market Adjustment LowerOfCostOrMarketAdjustment	0	usd
CY2024Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	167000	usd
CY2023Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	0	usd
CY2024Q1	us-gaap	Share Based Compensation ShareBasedCompensation	681000	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	739000	usd
CY2024Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	2513000	usd
CY2023Q1	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-11739000	usd
CY2024Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	532000	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	791000	usd
CY2024Q1	us-gaap	Proceeds From Sale Of Loans Held For Sale ProceedsFromSaleOfLoansHeldForSale	184332000	usd
CY2023Q1	us-gaap	Proceeds From Sale Of Loans Held For Sale ProceedsFromSaleOfLoansHeldForSale	121575000	usd
CY2024Q1	us-gaap	Payments To Purchase Loans Held For Sale PaymentsToPurchaseLoansHeldForSale	0	usd
CY2023Q1	us-gaap	Payments To Purchase Loans Held For Sale PaymentsToPurchaseLoansHeldForSale	5797000	usd
CY2024Q1	newt	Payments For Funding Of Investment Operating Activity PaymentsForFundingOfInvestmentOperatingActivity	255727000	usd
CY2023Q1	newt	Payments For Funding Of Investment Operating Activity PaymentsForFundingOfInvestmentOperatingActivity	156742000	usd
CY2024Q1	newt	Proceeds From Principal Received On Loans Held For Sale ProceedsFromPrincipalReceivedOnLoansHeldForSale	1638000	usd
CY2023Q1	newt	Proceeds From Principal Received On Loans Held For Sale ProceedsFromPrincipalReceivedOnLoansHeldForSale	1347000	usd
CY2024Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	0	usd
CY2023Q1	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-180000	usd
CY2024Q1	us-gaap	Increase Decrease In Brokerage Receivables IncreaseDecreaseInBrokerageReceivables	-5340000	usd
CY2023Q1	us-gaap	Increase Decrease In Brokerage Receivables IncreaseDecreaseInBrokerageReceivables	41427000	usd
CY2024Q1	newt	Increase Decrease In Servicing Asset IncreaseDecreaseInServicingAsset	0	usd
CY2023Q1	newt	Increase Decrease In Servicing Asset IncreaseDecreaseInServicingAsset	2164000	usd
CY2024Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	1430000	usd
CY2023Q1	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-6692000	usd
CY2024Q1	newt	Increase Decrease In Dividends Payable IncreaseDecreaseInDividendsPayable	246000	usd
CY2023Q1	newt	Increase Decrease In Dividends Payable IncreaseDecreaseInDividendsPayable	0	usd
CY2024Q1	newt	Increase Decrease In Due To Participants IncreaseDecreaseInDueToParticipants	2852000	usd
CY2023Q1	newt	Increase Decrease In Due To Participants IncreaseDecreaseInDueToParticipants	-7447000	usd
CY2024Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	4955000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-20816000	usd
CY2024Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	0	usd
CY2023Q1	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-41000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-38674000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-116359000	usd
CY2024Q1	newt	Payments To Acquire Loans Held For Investment At Fair Value PaymentsToAcquireLoansHeldForInvestmentAtFairValue	-21688000	usd
CY2023Q1	newt	Payments To Acquire Loans Held For Investment At Fair Value PaymentsToAcquireLoansHeldForInvestmentAtFairValue	7595000	usd
CY2024Q1	newt	Proceeds From Loans Held For Investment At Cost ProceedsFromLoansHeldForInvestmentAtCost	-62123000	usd
CY2023Q1	newt	Proceeds From Loans Held For Investment At Cost ProceedsFromLoansHeldForInvestmentAtCost	269000	usd
CY2024Q1	newt	Payments For Contributions To Joint Ventures PaymentsForContributionsToJointVentures	7243000	usd
CY2023Q1	newt	Payments For Contributions To Joint Ventures PaymentsForContributionsToJointVentures	0	usd
CY2024Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	57000	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	165000	usd
CY2024Q1	us-gaap	Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital	24000	usd
CY2023Q1	us-gaap	Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital	0	usd
CY2024Q1	us-gaap	Increase Decrease In Loans To Federal Home Loan Banks IncreaseDecreaseInLoansToFederalHomeLoanBanks	138000	usd
CY2023Q1	us-gaap	Increase Decrease In Loans To Federal Home Loan Banks IncreaseDecreaseInLoansToFederalHomeLoanBanks	-242000	usd
CY2024Q1	us-gaap	Proceeds From Sale Of Available For Sale Securities Debt ProceedsFromSaleOfAvailableForSaleSecuritiesDebt	4044000	usd
CY2023Q1	us-gaap	Payments To Acquire Available For Sale Securities Debt PaymentsToAcquireAvailableForSaleSecuritiesDebt	27901000	usd
CY2024Q1	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	usd
CY2023Q1	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	-11252000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-43805000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-23898000	usd
CY2024Q1	us-gaap	Proceeds From Repayments Of Notes Payable ProceedsFromRepaymentsOfNotesPayable	43814000	usd
CY2023Q1	us-gaap	Proceeds From Repayments Of Notes Payable ProceedsFromRepaymentsOfNotesPayable	47274000	usd
CY2024Q1	newt	Increase Decrease In Deposit Liabilities IncreaseDecreaseInDepositLiabilities	49098000	usd
CY2023Q1	newt	Increase Decrease In Deposit Liabilities IncreaseDecreaseInDepositLiabilities	105933000	usd
CY2024Q1	newt	Repayment Of Federal Home Loan Bank Advances RepaymentOfFederalHomeLoanBankAdvances	3484000	usd
CY2023Q1	newt	Repayment Of Federal Home Loan Bank Advances RepaymentOfFederalHomeLoanBankAdvances	3699000	usd
CY2024Q1	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	0	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	19493000	usd
CY2024Q1	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	22954000	usd
CY2023Q1	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	31015000	usd
CY2024Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	4771000	usd
CY2023Q1	us-gaap	Payments Of Dividends PaymentsOfDividends	0	usd
CY2024Q1	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	24000	usd
CY2023Q1	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	1087000	usd
CY2024Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	61679000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	186899000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-20800000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	46642000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	184006000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	125606000	usd
CY2024Q1	newt	Consolidation Of Cash From Investments ConsolidationOfCashFromInvestments	0	usd
CY2023Q1	newt	Consolidation Of Cash From Investments ConsolidationOfCashFromInvestments	24896000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	163206000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	197144000	usd
CY2024Q1	us-gaap	Transfer Of Other Real Estate TransferOfOtherRealEstate	1447000	usd
CY2023Q1	us-gaap	Transfer Of Other Real Estate TransferOfOtherRealEstate	694000	usd
CY2024Q1	newt	Dividends Incurred But Not Yet Paid DividendsIncurredButNotYetPaid	4617000	usd
CY2023Q1	newt	Dividends Incurred But Not Yet Paid DividendsIncurredButNotYetPaid	4363000	usd
CY2024Q1	us-gaap	Stock Issued1 StockIssued1	0	usd
CY2023Q1	us-gaap	Stock Issued1 StockIssued1	72000	usd
CY2024Q1	us-gaap	Interest Paid Net InterestPaidNet	19079000	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	12259000	usd
CY2024Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	73000	usd
CY2023Q1	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	4539000	usd
CY2024Q1	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reclassifications and Restatements</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain prior period amounts, to the extent comparable, have been reclassified to conform to the current period presentation. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, as disclosed in our 2023 Form 10-K, the Company’s prior year condensed comparative financial statements have been adjusted to correct errors made in the Company’s financial statements previously issued for the first, second, and third quarters of 2023. Balances as of and results for the three months ended March 31, 2023 are presented as restated. Refer to our 2023 Form 10-K for further detail.</span></div>
CY2024Q1	us-gaap	Cash Uninsured Amount CashUninsuredAmount	34200000	usd
CY2024Q1	us-gaap	Restricted Cash RestrictedCash	35800000	usd
CY2023Q4	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	19400000	usd
CY2024Q1	us-gaap	Payments For Purchase Of Investment Operating Activity PaymentsForPurchaseOfInvestmentOperatingActivity	0	usd
CY2024Q1	us-gaap	Proceeds From Disposition Of Investment Operating Activity ProceedsFromDispositionOfInvestmentOperatingActivity	0	usd
CY2024Q1	newt	Return Of Investment Operating Activity ReturnOfInvestmentOperatingActivity	0	usd
CY2024Q1	us-gaap	Debt And Equity Securities Realized Gain Loss DebtAndEquitySecuritiesRealizedGainLoss	0	usd
CY2024Q1	us-gaap	Debt And Equity Securities Unrealized Gain Loss DebtAndEquitySecuritiesUnrealizedGainLoss	-1150000	usd
CY2024Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	2700000	usd
CY2024Q1	us-gaap	Cash Cash	12295000	usd
CY2023Q1	us-gaap	Cash Cash	29103000	usd
CY2023Q4	us-gaap	Cash Cash	15398000	usd
CY2024Q1	us-gaap	Restricted Cash RestrictedCash	35759000	usd
CY2023Q1	us-gaap	Restricted Cash RestrictedCash	73421000	usd
CY2023Q4	us-gaap	Restricted Cash RestrictedCash	30919000	usd
CY2024Q1	us-gaap	Due From Banks DueFromBanks	115152000	usd
CY2023Q1	us-gaap	Due From Banks DueFromBanks	94620000	usd
CY2023Q4	us-gaap	Due From Banks DueFromBanks	137689000	usd
CY2024Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	163206000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	197144000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	184006000	usd
CY2024Q1	us-gaap	Financing Receivable Allowance For Credit Losses Policy For Uncollectible Amounts FinancingReceivableAllowanceForCreditLossesPolicyForUncollectibleAmounts	<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:112%">Allowance for Credit Losses – Loans</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounting Standards Update (“ASU”) 2016-13, Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (“CECL”) approach requires an estimate of the credit losses expected over the life of a loan (or pool of loans). The allowance for credit losses is a valuation account that is deducted from the loans’ amortized cost basis to present the net, lifetime amount expected to be collected on the loans. Loan losses are charged off against the allowance when management believes a loan balance is uncollectible. Expected recoveries do not exceed the aggregate of amounts previously charged-off and expected to be charged-off.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The allowance is comprised of reserves measured on a collective (pool) basis based on a lifetime loss-rate model when similar risk characteristics exist. Loans that do not share risk characteristics are evaluated on an individual basis, which generally includes larger non-accruing commercial loans.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The discounted cash flow (“DCF”) method is used to estimate expected credit losses for all loan portfolio segments measured on a collective (pool) basis. For each loan segment, cash flow projections are generated at the instrument level wherein payment expectations are adjusted for estimated prepayment speeds, probability of default, and loss given default. The modeling of prepayment speeds is based on a combination of historical internal data and peer data.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Regression analysis of historical internal and peer data is used to determine suitable loss drivers to utilize when modeling lifetime probability of default. This analysis also determines how expected probability of default and loss given default will react to forecasted levels of the loss drivers. The SBA 7(a) loan portfolio is the single loan pool where management solely utilizes historical internal data to determine the loss rate as an input to the model. The data utilized represents the most recent economic cycle and management determines the loss rate by analyzing defaulted principal and net charge offs to calculate the historical loss rate. For all loan pools utilizing the DCF method, management utilizes various economic indicators such as changes in unemployment rates, gross domestic product, real estate values, and other relevant factors as loss drivers. For all DCF models, management has determined that due to historic volatility in economic data, four quarters currently represents a reasonable and supportable forecast period, followed by a four-quarter reversion to historical mean levels for each of the various economic indicators.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The combination of adjustments for credit expectations (default and loss) and timing expectations (prepayment, curtailment, and time to recovery) produces an expected cash flow stream at the instrument level. Specific instrument effective yields are calculated, net of the impacts of prepayment assumptions, and the instrument expected cash flows are then discounted at that effective yield to produce an instrument-level Net Present Value (“NPV”). An allowance is established for the difference between the instrument’s NPV and amortized cost basis.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The allowance evaluation also considers various qualitative factors, such as: (i) changes to lending policies, underwriting standards and/or management personnel performing such functions, (ii) delinquency and other credit quality trends, (iii) credit risk concentrations, if any, (iv) changes to the nature of the Company's business impacting the loan portfolio, and (v) other external factors, that may include, but are not limited to, results of internal loan reviews, stress testing, examinations by bank regulatory agencies, or other events such as a natural disaster. Significant management judgment is required at each point in the measurement process.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Arriving at an appropriate level of allowance involves a high degree of judgment. The determination of the adequacy of the allowance and provisioning for estimated losses is evaluated regularly based on review of loans, with particular emphasis on non-performing and other loans that management believes warrant special consideration. While management uses available information to recognize losses on loans, changing economic conditions and the economic prospects of the borrowers may necessitate future additions or reductions to the allowance. Management estimates the allowance balance using relevant available information, from internal and external sources, related to past events, current conditions, and reasonable and supportable forecasts. The Company’s historical credit loss experience provides the basis for the estimation of expected credit losses, supplemented with peer loss information, and results in expected probabilities of default and expected losses given default. Adjustments to historical loss information are made for differences in current loan-specific risk characteristics such as differences in underwriting standards, portfolio mix, delinquency level, or term as well as changes in environmental conditions, such as changes in unemployment rates, production metrics, property values, or other relevant factors.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Expected losses are applied to loans grouped in portfolio segments, which are pools of loans aggregated based on type of borrower and collateral, generally based upon federal call report segmentation. Portfolio segments have been combined or sub-segmented as needed to ensure loans of similar risk profiles are appropriately pooled. These portfolio segments are as follows:</span></div><div><span><br/></span></div><div style="padding-left:45pt;text-indent:-45pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">CRE:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The CRE portfolio is comprised of loans to borrowers on small offices, owner-occupied commercial buildings, industrial/warehouse properties, income producing/investor real estate properties, and multi-family loans secured by first mortgages. The Company’s underwriting standards generally target a loan-to-value ratio of 75%, depending on the type of collateral, and requires debt service coverage of a minimum of 1.2 times.</span></div><div style="padding-left:45pt;text-align:justify;text-indent:-45pt"><span><br/></span></div><div style="padding-left:45pt;text-indent:-45pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">C&I:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The C&I portfolio consists of loans made for general business purposes consisting of short-term working capital loans, equipment loans and unsecured business lines. </span></div><div style="padding-left:45pt;text-indent:-45pt"><span><br/></span></div><div style="padding-left:45pt;text-indent:-45pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">SBA 7(a):</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The SBA 7(a) portfolio includes loans originated under the federal Section 7(a) loan program. The SBA is an independent government agency that facilitates one of the nation’s largest sources of SMB financing by providing credit guarantees for its loan programs. SBA 7(a) loans are partially guaranteed by the SBA, with SBA guarantees typically ranging between 50% and 90% of the principal and interest due. Under the SBA’s 7(a) lending program, a bank or other lender licensed by the SBA may underwrite loans between $5.0 thousand and $5.0 million for a variety of general business purposes based on the SBA’s loan program requirements. The guaranteed portion of the loans are held for sale and carried at LCM and therefore are not subject to CECL. The unguaranteed portion of the loans that are held on balance sheet at amortized cost are subject to CECL.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Individually Evaluated Loans. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Loans that do not share risk characteristics with existing pools are evaluated on an individual basis. For loans that are individually evaluated and collateral dependent, financial loans where management has determined that foreclosure of the collateral is probable, or where the borrower is experiencing financial difficulty and management expects repayment of the financial asset to be provided substantially through the sale of the collateral, the ACL is measured based on the difference between the fair value of the collateral and the amortized cost basis of the asset as of the measurement date. When repayment is expected to be from the operation of the collateral or going concern, the specific credit loss reserve is calculated as the amount by which the amortized cost basis of the financial asset exceeds the NPV from the operation of the collateral. When repayment is expected to be from the sale of the collateral, the specific credit loss reserve is calculated as the amount by which the amortized costs basis of the financial asset exceeds the fair value of the underlying collateral less estimated cost to sell. The allowance may be zero if the fair value of the collateral at the measurement date exceeds the amortized cost basis of the financial asset.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Accrued Interest. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued interest receivable balances are presented within other assets on the consolidated balance sheet. Accrued interest is excluded from the measurement of the allowance for credit losses, including investments and loans. Generally, accrued interest is reversed when a loan is placed on non-accrual or is written-off. Current year accrued interest is reversed through interest income while accrued interest from prior years is written-off through the ACL. Historically, we have not experienced uncollectible accrued interest receivable on investment debt securities.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Allowance for off-balance sheet credit exposures. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The exposure is a component of other liabilities in the consolidated balance sheet and represents the estimate for probable credit losses inherent in unfunded commitments to extend credit. Unfunded commitments to extend credit include unused portions of lines of credit and standby and commercial letters of credit. The process used to determine the allowance for these exposures is consistent with the process for determining the allowance for loans, as adjusted for estimated funding probabilities or loan equivalency factors. A charge (credit) to provision for credit losses on the consolidated statements of income is made to account for the change in the allowance on off-balance sheet exposures between reporting periods.</span></div>
CY2024Q1	newt	Financing Receivable Loan To Value Ratio FinancingReceivableLoanToValueRatio	0.75
CY2024Q1	newt	Debt Instrument Service Coverage Ratio Minimum DebtInstrumentServiceCoverageRatioMinimum	1.2
CY2023Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	5200000	usd
CY2023Q1	us-gaap	Debt And Equity Securities Realized Gain Loss DebtAndEquitySecuritiesRealizedGainLoss	0	usd
CY2023Q1	us-gaap	Debt And Equity Securities Unrealized Gain Loss DebtAndEquitySecuritiesUnrealizedGainLoss	0	usd
CY2023Q1	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	360000	usd
CY2023Q1	us-gaap	Dividend Income Operating DividendIncomeOperating	0	usd
CY2024Q1	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	18250000	usd
CY2024Q1	us-gaap	Dividend Income Operating DividendIncomeOperating	379000	usd
CY2023Q4	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	21459000	usd
CY2024Q1	us-gaap	Payments For Purchase Of Investment Operating Activity PaymentsForPurchaseOfInvestmentOperatingActivity	7243000	usd
CY2024Q1	us-gaap	Proceeds From Disposition Of Investment Operating Activity ProceedsFromDispositionOfInvestmentOperatingActivity	0	usd
CY2024Q1	newt	Return Of Investment Operating Activity ReturnOfInvestmentOperatingActivity	0	usd
CY2024Q1	us-gaap	Debt And Equity Securities Realized Gain Loss DebtAndEquitySecuritiesRealizedGainLoss	0	usd
CY2024Q1	us-gaap	Debt And Equity Securities Unrealized Gain Loss DebtAndEquitySecuritiesUnrealizedGainLoss	1295000	usd
CY2024Q1	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	29997000	usd
CY2024Q1	us-gaap	Dividend Income Operating DividendIncomeOperating	0	usd
CY2023Q4	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	368000	usd
CY2024Q1	us-gaap	Payments For Purchase Of Investment Operating Activity PaymentsForPurchaseOfInvestmentOperatingActivity	0	usd
CY2024Q1	us-gaap	Proceeds From Disposition Of Investment Operating Activity ProceedsFromDispositionOfInvestmentOperatingActivity	0	usd
CY2024Q1	newt	Return Of Investment Operating Activity ReturnOfInvestmentOperatingActivity	24000	usd
CY2024Q1	us-gaap	Debt And Equity Securities Realized Gain Loss DebtAndEquitySecuritiesRealizedGainLoss	0	usd
CY2024Q1	us-gaap	Debt And Equity Securities Unrealized Gain Loss DebtAndEquitySecuritiesUnrealizedGainLoss	24000	usd
CY2024Q1	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	368000	usd
CY2024Q1	us-gaap	Dividend Income Operating DividendIncomeOperating	7000	usd
CY2023Q4	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	360000	usd
CY2024Q1	us-gaap	Payments For Purchase Of Investment Operating Activity PaymentsForPurchaseOfInvestmentOperatingActivity	0	usd
CY2024Q1	us-gaap	Proceeds From Disposition Of Investment Operating Activity ProceedsFromDispositionOfInvestmentOperatingActivity	0	usd
CY2024Q1	newt	Return Of Investment Operating Activity ReturnOfInvestmentOperatingActivity	0	usd
CY2024Q1	us-gaap	Debt And Equity Securities Realized Gain Loss DebtAndEquitySecuritiesRealizedGainLoss	0	usd
CY2024Q1	us-gaap	Debt And Equity Securities Unrealized Gain Loss DebtAndEquitySecuritiesUnrealizedGainLoss	0	usd
CY2024Q1	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	360000	usd
CY2024Q1	us-gaap	Dividend Income Operating DividendIncomeOperating	0	usd
CY2022Q4	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	16587000	usd
CY2023Q1	us-gaap	Payments For Purchase Of Investment Operating Activity PaymentsForPurchaseOfInvestmentOperatingActivity	0	usd
CY2023Q1	us-gaap	Proceeds From Disposition Of Investment Operating Activity ProceedsFromDispositionOfInvestmentOperatingActivity	0	usd
CY2023Q1	newt	Return Of Investment Operating Activity ReturnOfInvestmentOperatingActivity	0	usd
CY2023Q1	us-gaap	Debt And Equity Securities Realized Gain Loss DebtAndEquitySecuritiesRealizedGainLoss	0	usd
CY2023Q1	us-gaap	Debt And Equity Securities Unrealized Gain Loss DebtAndEquitySecuritiesUnrealizedGainLoss	2313000	usd
CY2023Q1	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	18900000	usd
CY2023Q1	us-gaap	Dividend Income Operating DividendIncomeOperating	484000	usd
CY2022Q4	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	6435000	usd
CY2023Q1	us-gaap	Payments For Purchase Of Investment Operating Activity PaymentsForPurchaseOfInvestmentOperatingActivity	0	usd
CY2023Q1	us-gaap	Proceeds From Disposition Of Investment Operating Activity ProceedsFromDispositionOfInvestmentOperatingActivity	0	usd
CY2023Q1	newt	Return Of Investment Operating Activity ReturnOfInvestmentOperatingActivity	0	usd
CY2023Q1	us-gaap	Debt And Equity Securities Realized Gain Loss DebtAndEquitySecuritiesRealizedGainLoss	0	usd
CY2023Q1	us-gaap	Debt And Equity Securities Unrealized Gain Loss DebtAndEquitySecuritiesUnrealizedGainLoss	-313000	usd
CY2023Q1	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	6122000	usd
CY2023Q1	us-gaap	Dividend Income Operating DividendIncomeOperating	0	usd
CY2022Q4	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	1000000	usd
CY2023Q1	us-gaap	Payments For Purchase Of Investment Operating Activity PaymentsForPurchaseOfInvestmentOperatingActivity	0	usd
CY2023Q1	us-gaap	Proceeds From Disposition Of Investment Operating Activity ProceedsFromDispositionOfInvestmentOperatingActivity	0	usd
CY2023Q1	newt	Return Of Investment Operating Activity ReturnOfInvestmentOperatingActivity	0	usd
CY2023Q1	us-gaap	Debt And Equity Securities Realized Gain Loss DebtAndEquitySecuritiesRealizedGainLoss	0	usd
CY2023Q1	us-gaap	Debt And Equity Securities Unrealized Gain Loss DebtAndEquitySecuritiesUnrealizedGainLoss	0	usd
CY2023Q1	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	1000000	usd
CY2023Q1	us-gaap	Dividend Income Operating DividendIncomeOperating	20000	usd
CY2022Q4	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	360000	usd
CY2023Q1	us-gaap	Payments For Purchase Of Investment Operating Activity PaymentsForPurchaseOfInvestmentOperatingActivity	0	usd
CY2023Q1	us-gaap	Proceeds From Disposition Of Investment Operating Activity ProceedsFromDispositionOfInvestmentOperatingActivity	0	usd
CY2023Q1	newt	Return Of Investment Operating Activity ReturnOfInvestmentOperatingActivity	0	usd
CY2024Q1	us-gaap	Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest After Allowance For Credit Loss DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss	28319000	usd
CY2024Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	0	usd
CY2024Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	192000	usd
CY2024Q1	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest DebtSecuritiesAvailableForSaleExcludingAccruedInterest	28127000	usd
CY2023Q4	us-gaap	Debt Securities Available For Sale Amortized Cost Excluding Accrued Interest After Allowance For Credit Loss DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss	32372000	usd
CY2023Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	0	usd
CY2023Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	201000	usd
CY2023Q4	us-gaap	Debt Securities Available For Sale Excluding Accrued Interest DebtSecuritiesAvailableForSaleExcludingAccruedInterest	32171000	usd
CY2024Q1	us-gaap	Debt Securities Available For Sale Accrued Interest After Allowance For Credit Loss DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss	13900	usd
CY2023Q4	us-gaap	Debt Securities Available For Sale Accrued Interest After Allowance For Credit Loss DebtSecuritiesAvailableForSaleAccruedInterestAfterAllowanceForCreditLoss	200000	usd
CY2024Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months	28127000	usd
CY2024Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	192000	usd
CY2024Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	0	usd
CY2024Q1	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	0	usd
CY2024Q1	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Number Of Positions DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions	3	loan
CY2024Q1	us-gaap	Debt Securities Available For Sale Unrealized Loss Position DebtSecuritiesAvailableForSaleUnrealizedLossPosition	28127000	usd
CY2024Q1	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss	192000	usd
CY2023Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months	32171000	usd
CY2023Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss	201000	usd
CY2023Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger	0	usd
CY2023Q4	us-gaap	Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss	0	usd
CY2023Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Number Of Positions DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions	3	loan
CY2023Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position DebtSecuritiesAvailableForSaleUnrealizedLossPosition	32172000	usd
CY2023Q4	us-gaap	Debt Securities Available For Sale Unrealized Loss Position Accumulated Loss DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss	201000	usd
CY2024Q1	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	16713000	usd
CY2024Q1	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	16588000	usd
CY2023Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost	32372000	usd
CY2023Q4	us-gaap	Available For Sale Securities Debt Maturities Within One Year Fair Value AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue	32171000	usd
CY2024Q1	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	11606000	usd
CY2024Q1	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	11539000	usd
CY2023Q4	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost	0	usd
CY2023Q4	us-gaap	Available For Sale Securities Debt Maturities After One Through Five Years Fair Value AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue	0	usd
CY2024Q1	us-gaap	Available For Sale Securities Debt Maturities Single Maturity Date Amortized Cost Basis AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis	28319000	usd
CY2024Q1	us-gaap	Available For Sale Securities Debt Maturities Single Maturity Date AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate	28127000	usd
CY2023Q4	us-gaap	Available For Sale Securities Debt Maturities Single Maturity Date Amortized Cost Basis AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis	32372000	usd
CY2023Q4	us-gaap	Available For Sale Securities Debt Maturities Single Maturity Date AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate	32171000	usd
CY2024Q1	newt	Pledged Financial Instruments Not Separately Reported Debt Securities Available For Sale PledgedFinancialInstrumentsNotSeparatelyReportedDebtSecuritiesAvailableForSale	28127000	usd
CY2023Q4	newt	Pledged Financial Instruments Not Separately Reported Debt Securities Available For Sale PledgedFinancialInstrumentsNotSeparatelyReportedDebtSecuritiesAvailableForSale	30730000	usd
CY2024Q1	newt	Financing Receivable Before Allowance For Credit Loss Amortized Cost Industry Loans FinancingReceivableBeforeAllowanceForCreditLossAmortizedCostIndustryLoans	457581000	usd
CY2024Q1	newt	Financing Receivable Before Allowance For Credit Loss Fair Value Industry Loans FinancingReceivableBeforeAllowanceForCreditLossFairValueIndustryLoans	442928000	usd
CY2023Q4	newt	Financing Receivable Before Allowance For Credit Loss Amortized Cost Industry Loans FinancingReceivableBeforeAllowanceForCreditLossAmortizedCostIndustryLoans	482563000	usd
CY2023Q4	newt	Financing Receivable Before Allowance For Credit Loss Fair Value Industry Loans FinancingReceivableBeforeAllowanceForCreditLossFairValueIndustryLoans	469801000	usd
CY2024Q1	newt	Financing Receivable Before Allowance For Credit Loss Deferred Loan Fees FinancingReceivableBeforeAllowanceForCreditLossDeferredLoanFees	314000	usd
CY2023Q4	newt	Financing Receivable Before Allowance For Credit Loss Deferred Loan Fees FinancingReceivableBeforeAllowanceForCreditLossDeferredLoanFees	393000	usd
CY2024Q1	newt	Financing Receivable Before Allowance For Credit Loss After Deferred Loan Fees FinancingReceivableBeforeAllowanceForCreditLossAfterDeferredLoanFees	397625000	usd
CY2023Q4	newt	Financing Receivable Before Allowance For Credit Loss After Deferred Loan Fees FinancingReceivableBeforeAllowanceForCreditLossAfterDeferredLoanFees	336305000	usd
CY2024Q1	newt	Financing Receivable Before Allowance For Credit Loss Deferred Loan Fees FinancingReceivableBeforeAllowanceForCreditLossDeferredLoanFees	314000	usd
CY2024Q1	newt	Financing Receivable Before Allowance For Credit Loss Deferred Loan Fees FinancingReceivableBeforeAllowanceForCreditLossDeferredLoanFees	314000	usd
CY2024Q1	us-gaap	Notes Receivable Gross NotesReceivableGross	397625000	usd
CY2024Q1	us-gaap	Notes Receivable Gross NotesReceivableGross	397625000	usd
CY2024Q1	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	16126000	usd
CY2024Q1	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	16126000	usd
CY2024Q1	us-gaap	Notes Receivable Net NotesReceivableNet	381499000	usd
CY2024Q1	us-gaap	Notes Receivable Net NotesReceivableNet	381499000	usd
CY2024Q1	newt	Financing Receivable Before Allowance For Credit Loss Fair Value Disclosure FinancingReceivableBeforeAllowanceForCreditLossFairValueDisclosure	442928000	usd
CY2024Q1	newt	Financing Receivable Before Allowance For Credit Loss Fair Value Disclosure FinancingReceivableBeforeAllowanceForCreditLossFairValueDisclosure	442928000	usd
CY2024Q1	us-gaap	Notes Receivable Net NotesReceivableNet	381499000	usd
CY2024Q1	newt	Financing Receivable Before Allowance For Credit Loss Fair Value Disclosure FinancingReceivableBeforeAllowanceForCreditLossFairValueDisclosure	442928000	usd
CY2024Q1	newt	Financing Receivable Before Allowance For Credit Loss Amortized Cost And Fair Value FinancingReceivableBeforeAllowanceForCreditLossAmortizedCostAndFairValue	824427000	usd
CY2023Q4	newt	Financing Receivable Before Allowance For Credit Loss Deferred Loan Fees FinancingReceivableBeforeAllowanceForCreditLossDeferredLoanFees	393000	usd
CY2023Q4	newt	Financing Receivable Before Allowance For Credit Loss Deferred Loan Fees FinancingReceivableBeforeAllowanceForCreditLossDeferredLoanFees	393000	usd
CY2023Q4	us-gaap	Notes Receivable Gross NotesReceivableGross	336305000	usd
CY2023Q4	us-gaap	Notes Receivable Gross NotesReceivableGross	336305000	usd
CY2023Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	12574000	usd
CY2023Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	12574000	usd
CY2023Q4	us-gaap	Notes Receivable Net NotesReceivableNet	323731000	usd
CY2023Q4	us-gaap	Notes Receivable Net NotesReceivableNet	323731000	usd
CY2023Q4	newt	Financing Receivable Before Allowance For Credit Loss Fair Value Disclosure FinancingReceivableBeforeAllowanceForCreditLossFairValueDisclosure	469801000	usd
CY2023Q4	newt	Financing Receivable Before Allowance For Credit Loss Fair Value Disclosure FinancingReceivableBeforeAllowanceForCreditLossFairValueDisclosure	469801000	usd
CY2023Q4	us-gaap	Notes Receivable Net NotesReceivableNet	323731000	usd
CY2023Q4	newt	Financing Receivable Before Allowance For Credit Loss Fair Value Disclosure FinancingReceivableBeforeAllowanceForCreditLossFairValueDisclosure	469801000	usd
CY2023Q4	newt	Financing Receivable Before Allowance For Credit Loss Amortized Cost And Fair Value FinancingReceivableBeforeAllowanceForCreditLossAmortizedCostAndFairValue	793532000	usd
CY2023Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	12574000	usd
CY2022Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	0	usd
CY2023Q4	newt	Financing Receivable Allowance For Credit Loss Adjusted Opening Balance FinancingReceivableAllowanceForCreditLossAdjustedOpeningBalance	0	usd
CY2022Q4	newt	Financing Receivable Allowance For Credit Loss Adjusted Opening Balance FinancingReceivableAllowanceForCreditLossAdjustedOpeningBalance	871000	usd
CY2024Q1	us-gaap	Financing Receivable Allowance For Credit Losses Write Offs FinancingReceivableAllowanceForCreditLossesWriteOffs	370000	usd
CY2023Q1	us-gaap	Financing Receivable Allowance For Credit Losses Write Offs FinancingReceivableAllowanceForCreditLossesWriteOffs	0	usd
CY2024Q1	us-gaap	Financing Receivable Allowance For Credit Losses Recovery FinancingReceivableAllowanceForCreditLossesRecovery	0	usd
CY2023Q1	us-gaap	Financing Receivable Allowance For Credit Losses Recovery FinancingReceivableAllowanceForCreditLossesRecovery	0	usd
CY2024Q1	newt	Financing Receivable Credit Loss Expense Reversal Excluding Unfunded Commitments FinancingReceivableCreditLossExpenseReversalExcludingUnfundedCommitments	3922000	usd
CY2023Q1	newt	Financing Receivable Credit Loss Expense Reversal Excluding Unfunded Commitments FinancingReceivableCreditLossExpenseReversalExcludingUnfundedCommitments	1318000	usd
CY2024Q1	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	16126000	usd
CY2024Q1	newt	Financing Receivable Held For Sale Before Deferred Fees And Costs FinancingReceivableHeldForSaleBeforeDeferredFeesAndCosts	187104000	usd
CY2024Q1	newt	Financing Receivable Held For Sale Lower Of Cost Or Market Before Deferred Fees And Costs FinancingReceivableHeldForSaleLowerOfCostOrMarketBeforeDeferredFeesAndCosts	59021000	usd
CY2023Q4	newt	Financing Receivable Held For Sale Before Deferred Fees And Costs FinancingReceivableHeldForSaleBeforeDeferredFeesAndCosts	118867000	usd
CY2023Q4	newt	Financing Receivable Held For Sale Lower Of Cost Or Market Before Deferred Fees And Costs FinancingReceivableHeldForSaleLowerOfCostOrMarketBeforeDeferredFeesAndCosts	55829000	usd
CY2023Q1	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	2189000	usd
CY2024Q1	newt	Financing Receivable Credit Loss Expense Reversal Unfunded Commitments FinancingReceivableCreditLossExpenseReversalUnfundedCommitments	93000	usd
CY2024Q1	us-gaap	Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1 FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1	711000	usd
CY2023Q4	us-gaap	Financing Receivable Allowance For Credit Losses Individually Evaluated For Impairment1 FinancingReceivableAllowanceForCreditLossesIndividuallyEvaluatedForImpairment1	102000	usd
CY2024Q1	us-gaap	Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment	15415000	usd
CY2023Q4	us-gaap	Financing Receivable Allowance For Credit Losses Collectively Evaluated For Impairment FinancingReceivableAllowanceForCreditLossesCollectivelyEvaluatedForImpairment	12472000	usd
CY2024Q1	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	16126000	usd
CY2023Q4	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	12574000	usd
CY2024Q1	us-gaap	Financing Receivable Individually Evaluated For Impairment FinancingReceivableIndividuallyEvaluatedForImpairment	7879000	usd
CY2023Q4	us-gaap	Financing Receivable Individually Evaluated For Impairment FinancingReceivableIndividuallyEvaluatedForImpairment	5348000	usd
CY2024Q1	us-gaap	Financing Receivable Collectively Evaluated For Impairment FinancingReceivableCollectivelyEvaluatedForImpairment	389432000	usd
CY2023Q4	us-gaap	Financing Receivable Collectively Evaluated For Impairment FinancingReceivableCollectivelyEvaluatedForImpairment	330564000	usd
CY2024Q1	us-gaap	Financing Receivable Nonaccrual No Allowance FinancingReceivableNonaccrualNoAllowance	6708000	usd
CY2024Q1	us-gaap	Financing Receivable Recorded Investment Nonaccrual Status FinancingReceivableRecordedInvestmentNonaccrualStatus	1171000	usd
CY2024Q1	us-gaap	Impaired Financing Receivable Related Allowance ImpairedFinancingReceivableRelatedAllowance	711000	usd
CY2023Q4	us-gaap	Financing Receivable Nonaccrual No Allowance FinancingReceivableNonaccrualNoAllowance	5246000	usd
CY2023Q4	us-gaap	Financing Receivable Recorded Investment Nonaccrual Status FinancingReceivableRecordedInvestmentNonaccrualStatus	102000	usd
CY2023Q4	us-gaap	Impaired Financing Receivable Related Allowance ImpairedFinancingReceivableRelatedAllowance	102000	usd
CY2024Q1	us-gaap	Impaired Financing Receivable Unpaid Principal Balance ImpairedFinancingReceivableUnpaidPrincipalBalance	7879000	usd
CY2024Q1	us-gaap	Impaired Financing Receivable Related Allowance ImpairedFinancingReceivableRelatedAllowance	711000	usd
CY2023Q4	us-gaap	Impaired Financing Receivable Unpaid Principal Balance ImpairedFinancingReceivableUnpaidPrincipalBalance	5348000	usd
CY2023Q4	us-gaap	Impaired Financing Receivable Related Allowance ImpairedFinancingReceivableRelatedAllowance	102000	usd
CY2024Q1	us-gaap	Financing Receivable Accrued Interest Before Allowance For Credit Loss FinancingReceivableAccruedInterestBeforeAllowanceForCreditLoss	13700000	usd
CY2024Q1	newt	Financing Receivable Before Allowance For Credit Loss Deferred Loan Fees Held For Sale FinancingReceivableBeforeAllowanceForCreditLossDeferredLoanFeesHeldForSale	0	usd
CY2024Q1	newt	Financing Receivable Before Allowance For Credit Loss Deferred Loan Fees Held For Sale Lower Of Cost Or Market FinancingReceivableBeforeAllowanceForCreditLossDeferredLoanFeesHeldForSaleLowerOfCostOrMarket	859000	usd
CY2023Q4	newt	Financing Receivable Before Allowance For Credit Loss Deferred Loan Fees Held For Sale FinancingReceivableBeforeAllowanceForCreditLossDeferredLoanFeesHeldForSale	0	usd
CY2023Q4	newt	Financing Receivable Before Allowance For Credit Loss Deferred Loan Fees Held For Sale Lower Of Cost Or Market FinancingReceivableBeforeAllowanceForCreditLossDeferredLoanFeesHeldForSaleLowerOfCostOrMarket	778000	usd
CY2024Q1	us-gaap	Loans Receivable Held For Sale Amount LoansReceivableHeldForSaleAmount	187104000	usd
CY2024Q1	newt	Financing Receivable Held For Sale Lower Of Cost Or Market FinancingReceivableHeldForSaleLowerOfCostOrMarket	59880000	usd
CY2023Q4	us-gaap	Loans Receivable Held For Sale Amount LoansReceivableHeldForSaleAmount	118867000	usd
CY2023Q4	newt	Financing Receivable Held For Sale Lower Of Cost Or Market FinancingReceivableHeldForSaleLowerOfCostOrMarket	56607000	usd
CY2024Q1	us-gaap	Servicing Asset ServicingAsset	41172000	usd
CY2023Q4	us-gaap	Servicing Asset ServicingAsset	39725000	usd
CY2024Q1	us-gaap	Goodwill Goodwill	25885000	usd
CY2023Q4	us-gaap	Goodwill Goodwill	25885000	usd
CY2023Q1	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	300000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	7565000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	3506000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	4059000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	16140000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	11905000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	4235000	usd
CY2024Q1	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	200000	usd
CY2023Q1	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	400000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	480000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	622000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	601000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	580000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	560000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	1216000	usd
CY2024Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	4059000	usd
CY2024Q1	us-gaap	Other Real Estate OtherRealEstate	2438000	usd
CY2024Q1	us-gaap	Servicing Asset At Fair Value Amount ServicingAssetAtFairValueAmount	27601000	usd
CY2024Q1	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	737173000	usd
CY2024Q1	us-gaap	Derivative Liabilities DerivativeLiabilities	38000	usd
CY2024Q1	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	114000	usd
CY2023Q4	us-gaap	Other Real Estate OtherRealEstate	1110000	usd
CY2023Q4	us-gaap	Servicing Asset At Fair Value Amount ServicingAssetAtFairValueAmount	29336000	usd
CY2023Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	692872000	usd
CY2023Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	630000	usd
CY2023Q4	us-gaap	Liabilities Fair Value Disclosure LiabilitiesFairValueDisclosure	771000	usd
CY2024Q1	us-gaap	Cash Cash	12295000	usd
CY2024Q1	us-gaap	Restricted Cash RestrictedCash	35759000	usd
CY2024Q1	us-gaap	Due From Banks DueFromBanks	115152000	usd
CY2024Q1	us-gaap	Marketable Securities MarketableSecurities	28127000	usd
CY2024Q1	newt	Marketable Securities Fair Value Disclosure MarketableSecuritiesFairValueDisclosure	28127000	usd
CY2024Q1	us-gaap	Loans Receivable Held For Sale Amount LoansReceivableHeldForSaleAmount	187104000	usd
CY2024Q1	newt	Financing Receivable Held For Sale Fair Value Disclosure FinancingReceivableHeldForSaleFairValueDisclosure	187104000	usd
CY2024Q1	newt	Financing Receivable Held For Sale Lower Of Cost Or Market FinancingReceivableHeldForSaleLowerOfCostOrMarket	59880000	usd
CY2024Q1	newt	Financing Receivable Held For Sale Lower Of Cost Or Market Fair Value Disclosure FinancingReceivableHeldForSaleLowerOfCostOrMarketFairValueDisclosure	60227000	usd
CY2024Q1	newt	Financing Receivable Before Allowance For Credit Loss Fair Value Disclosure FinancingReceivableBeforeAllowanceForCreditLossFairValueDisclosure	442928000	usd
CY2024Q1	newt	Financing Receivable Before Allowance For Credit Loss Fair Value Disclosure FinancingReceivableBeforeAllowanceForCreditLossFairValueDisclosure	442928000	usd
CY2024Q1	us-gaap	Notes Receivable Gross NotesReceivableGross	397625000	usd
CY2024Q1	newt	Financing Receivable Fair Value Disclosure FinancingReceivableFairValueDisclosure	398453000	usd
CY2024Q1	us-gaap	Federal Home Loan Bank Stock And Federal Reserve Bank Stock FederalHomeLoanBankStockAndFederalReserveBankStock	3773000	usd
CY2024Q1	us-gaap	Investment In Federal Home Loan Bank Stock Fair Value Disclosure InvestmentInFederalHomeLoanBankStockFairValueDisclosure	3773000	usd
CY2024Q1	us-gaap	Interest Bearing Domestic Deposit Time Deposits InterestBearingDomesticDepositTimeDeposits	209721000	usd
CY2024Q1	us-gaap	Deposits Fair Value Disclosure DepositsFairValueDisclosure	210519000	usd
CY2024Q1	us-gaap	Long Term Debt LongTermDebt	662488000	usd
CY2024Q1	us-gaap	Long Term Debt Fair Value LongTermDebtFairValue	662304000	usd
CY2023Q4	us-gaap	Cash Cash	15398000	usd
CY2023Q4	us-gaap	Restricted Cash RestrictedCash	30919000	usd
CY2023Q4	us-gaap	Due From Banks DueFromBanks	137689000	usd
CY2023Q4	us-gaap	Marketable Securities MarketableSecurities	32171000	usd
CY2023Q4	newt	Marketable Securities Fair Value Disclosure MarketableSecuritiesFairValueDisclosure	32171000	usd
CY2023Q4	us-gaap	Loans Receivable Held For Sale Amount LoansReceivableHeldForSaleAmount	118867000	usd
CY2023Q4	newt	Financing Receivable Held For Sale Fair Value Disclosure FinancingReceivableHeldForSaleFairValueDisclosure	118867000	usd
CY2023Q4	newt	Financing Receivable Held For Sale Lower Of Cost Or Market FinancingReceivableHeldForSaleLowerOfCostOrMarket	56607000	usd
CY2023Q4	newt	Financing Receivable Held For Sale Lower Of Cost Or Market Fair Value Disclosure FinancingReceivableHeldForSaleLowerOfCostOrMarketFairValueDisclosure	56733000	usd
CY2023Q4	newt	Financing Receivable Before Allowance For Credit Loss Fair Value Disclosure FinancingReceivableBeforeAllowanceForCreditLossFairValueDisclosure	469801000	usd
CY2023Q4	newt	Financing Receivable Before Allowance For Credit Loss Fair Value Disclosure FinancingReceivableBeforeAllowanceForCreditLossFairValueDisclosure	469801000	usd
CY2023Q4	us-gaap	Notes Receivable Gross NotesReceivableGross	336305000	usd
CY2023Q4	newt	Financing Receivable Fair Value Disclosure FinancingReceivableFairValueDisclosure	337133000	usd
CY2023Q4	us-gaap	Federal Home Loan Bank Stock And Federal Reserve Bank Stock FederalHomeLoanBankStockAndFederalReserveBankStock	3635000	usd
CY2023Q4	us-gaap	Investment In Federal Home Loan Bank Stock Fair Value Disclosure InvestmentInFederalHomeLoanBankStockFairValueDisclosure	3635000	usd
CY2023Q4	us-gaap	Interest Bearing Domestic Deposit Time Deposits InterestBearingDomesticDepositTimeDeposits	167041000	usd
CY2023Q4	us-gaap	Deposits Fair Value Disclosure DepositsFairValueDisclosure	168542000	usd
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	644122000	usd
CY2023Q4	us-gaap	Long Term Debt Fair Value LongTermDebtFairValue	641794000	usd
CY2024Q1	us-gaap	Noninterest Bearing Deposit Liabilities NoninterestBearingDepositLiabilities	5466000	usd
CY2023Q4	us-gaap	Noninterest Bearing Deposit Liabilities NoninterestBearingDepositLiabilities	10053000	usd
CY2024Q1	us-gaap	Interest Bearing Domestic Deposit Checking InterestBearingDomesticDepositChecking	16870000	usd
CY2023Q4	us-gaap	Interest Bearing Domestic Deposit Checking InterestBearingDomesticDepositChecking	11456000	usd
CY2024Q1	us-gaap	Interest Bearing Domestic Deposit Money Market InterestBearingDomesticDepositMoneyMarket	27290000	usd
CY2023Q4	us-gaap	Interest Bearing Domestic Deposit Money Market InterestBearingDomesticDepositMoneyMarket	15803000	usd
CY2024Q1	us-gaap	Interest Bearing Domestic Deposit Savings InterestBearingDomesticDepositSavings	253595000	usd
CY2023Q4	us-gaap	Interest Bearing Domestic Deposit Savings InterestBearingDomesticDepositSavings	259152000	usd
CY2024Q1	us-gaap	Interest Bearing Domestic Deposit Time Deposits InterestBearingDomesticDepositTimeDeposits	209721000	usd
CY2023Q4	us-gaap	Interest Bearing Domestic Deposit Time Deposits InterestBearingDomesticDepositTimeDeposits	167041000	usd
CY2024Q1	us-gaap	Interest Bearing Deposit Liabilities InterestBearingDepositLiabilities	507476000	usd
CY2023Q4	us-gaap	Interest Bearing Deposit Liabilities InterestBearingDepositLiabilities	453452000	usd
CY2024Q1	us-gaap	Deposits Deposits	512942000	usd
CY2023Q4	us-gaap	Deposits Deposits	463505000	usd
CY2024Q1	us-gaap	Interest Bearing Domestic Deposit Brokered InterestBearingDomesticDepositBrokered	58295000	usd
CY2023Q4	us-gaap	Interest Bearing Domestic Deposit Brokered InterestBearingDomesticDepositBrokered	53548000	usd
CY2024Q1	us-gaap	Time Deposits At Or Above Fdic Insurance Limit TimeDepositsAtOrAboveFDICInsuranceLimit	74699000	usd
CY2023Q4	us-gaap	Time Deposits At Or Above Fdic Insurance Limit TimeDepositsAtOrAboveFDICInsuranceLimit	66511000	usd
CY2024Q1	us-gaap	Deposit Liabilities Reclassified As Loans Receivable1 DepositLiabilitiesReclassifiedAsLoansReceivable1	2000	usd
CY2023Q4	us-gaap	Deposit Liabilities Reclassified As Loans Receivable1 DepositLiabilitiesReclassifiedAsLoansReceivable1	53000	usd
CY2024Q1	us-gaap	Time Deposit Maturities Year One TimeDepositMaturitiesYearOne	92829000	usd
CY2024Q1	us-gaap	Time Deposit Maturities Year Two TimeDepositMaturitiesYearTwo	64999000	usd
CY2024Q1	us-gaap	Time Deposit Maturities Year Three TimeDepositMaturitiesYearThree	31530000	usd
CY2024Q1	us-gaap	Time Deposit Maturities Year Four TimeDepositMaturitiesYearFour	19574000	usd
CY2024Q1	us-gaap	Time Deposit Maturities Year Five TimeDepositMaturitiesYearFive	711000	usd
CY2024Q1	us-gaap	Time Deposit Maturities After Year Five TimeDepositMaturitiesAfterYearFive	78000	usd
CY2024Q1	us-gaap	Time Deposits TimeDeposits	209721000	usd
CY2024Q1	newt	Debt Instrument Maximum Borrowing Capacity Amount Outstanding DebtInstrumentMaximumBorrowingCapacityAmountOutstanding	851823000	usd
CY2024Q1	us-gaap	Long Term Debt LongTermDebt	662488000	usd
CY2024Q1	us-gaap	Debt Weighted Average Interest Rate DebtWeightedAverageInterestRate	0.0721
CY2023Q4	newt	Debt Instrument Maximum Borrowing Capacity Amount Outstanding DebtInstrumentMaximumBorrowingCapacityAmountOutstanding	878235000	usd
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	644122000	usd
CY2023Q4	us-gaap	Debt Weighted Average Interest Rate DebtWeightedAverageInterestRate	0.0704
CY2024Q1	us-gaap	Federal Home Loan Bank Advances Valuation Adjustments Under Fair Value Option FederalHomeLoanBankAdvancesValuationAdjustmentsUnderFairValueOption	-100000	usd
CY2024Q1	us-gaap	Contractual Obligation Due After Fifth Year ContractualObligationDueAfterFifthYear	0	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	2075000	usd
CY2024Q1	newt	Employment Agreement To Be Paid Year One EmploymentAgreementToBePaidYearOne	2274000	usd
CY2024Q1	us-gaap	Contractual Obligation Due In Next Twelve Months ContractualObligationDueInNextTwelveMonths	4349000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	2461000	usd
CY2024Q1	newt	Employment Agreement To Be Paid Year Two EmploymentAgreementToBePaidYearTwo	740000	usd
CY2024Q1	us-gaap	Contractual Obligation Due In Second Year ContractualObligationDueInSecondYear	3201000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	1835000	usd
CY2024Q1	newt	Employment Agreement To Be Paid Year Three EmploymentAgreementToBePaidYearThree	0	usd
CY2024Q1	us-gaap	Contractual Obligation Due In Third Year ContractualObligationDueInThirdYear	1835000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	429000	usd
CY2024Q1	newt	Employment Agreement To Be Paid Year Four EmploymentAgreementToBePaidYearFour	0	usd
CY2024Q1	us-gaap	Contractual Obligation Due In Fourth Year ContractualObligationDueInFourthYear	429000	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	0	usd
CY2024Q1	newt	Employment Agreement To Be Paid Year Five EmploymentAgreementToBePaidYearFive	0	usd
CY2024Q1	us-gaap	Contractual Obligation Due In Fifth Year ContractualObligationDueInFifthYear	0	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	0	usd
CY2024Q1	newt	Employment Agreement To Be Paid After Year Five EmploymentAgreementToBePaidAfterYearFive	0	usd
CY2024Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	6800000	usd
CY2024Q1	newt	Employment Agreement To Be Paid EmploymentAgreementToBePaid	3014000	usd
CY2024Q1	us-gaap	Contractual Obligation ContractualObligation	9814000	usd
CY2024Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	700000	usd
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	700000	usd
CY2023Q1	us-gaap	Class Of Warrant Or Right Unissued ClassOfWarrantOrRightUnissued	47540	shares
CY2023Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	21.03468
CY2024Q1	us-gaap	Dividends Preferred Stock DividendsPreferredStock	400000	usd
CY2023	us-gaap	Dividends Preferred Stock DividendsPreferredStock	200000	usd
CY2023Q2	us-gaap	Investment Company Distribution To Shareholders Per Share InvestmentCompanyDistributionToShareholdersPerShare	0.18
CY2023Q2	us-gaap	Investment Company Dividend Distribution InvestmentCompanyDividendDistribution	4291000	usd
CY2023Q2	us-gaap	Stock Issued During Period Shares Dividend Reinvestment Plan StockIssuedDuringPeriodSharesDividendReinvestmentPlan	6000	shares
CY2023Q2	us-gaap	Stock Issued During Period Value Dividend Reinvestment Plan StockIssuedDuringPeriodValueDividendReinvestmentPlan	72000	usd
CY2024Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	9250000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	18301000	usd
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	24287000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	24223000	shares
CY2024Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.38
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.76
CY2024Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	9250000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	18301000	usd
CY2024Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	24287000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	24223000	shares
CY2024Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	71000	shares
CY2023Q1	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	658000	shares
CY2024Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	24358000	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	24881000	shares
CY2024Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.38
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.74
CY2024Q1	us-gaap	Amount Of Dilutive Securities Stock Options And Restrictive Stock Units AmountOfDilutiveSecuritiesStockOptionsAndRestrictiveStockUnits	1065000	usd
CY2023Q1	us-gaap	Amount Of Dilutive Securities Stock Options And Restrictive Stock Units AmountOfDilutiveSecuritiesStockOptionsAndRestrictiveStockUnits	248000	usd
CY2024Q1	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.2633
CY2022Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	35400000	usd
CY2024Q1	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	4	segment
CY2024Q1	us-gaap	Interest Income Operating InterestIncomeOperating	27067000	usd
CY2024Q1	us-gaap	Interest Expense InterestExpense	18161000	usd
CY2024Q1	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	8906000	usd
CY2024Q1	us-gaap	Provision For Loan Lease And Other Losses ProvisionForLoanLeaseAndOtherLosses	4015000	usd
CY2024Q1	us-gaap	Interest Income Expense After Provision For Loan Loss InterestIncomeExpenseAfterProvisionForLoanLoss	4891000	usd
CY2024Q1	us-gaap	Noninterest Income NoninterestIncome	49367000	usd
CY2024Q1	us-gaap	Noninterest Expense NoninterestExpense	41159000	usd
CY2024Q1	us-gaap	Income Loss Attributable To Parent IncomeLossAttributableToParent	13099000	usd
CY2024Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	3449000	usd
CY2024Q1	us-gaap	Net Income Loss NetIncomeLoss	9650000	usd
CY2024Q1	us-gaap	Assets Assets	1509577000	usd
CY2024Q1	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q1	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false

Files In Submission

Name	View Source	Status
0001587987-24-000082-index-headers.html	Edgar Link	pending
0001587987-24-000082-index.html	Edgar Link	pending
0001587987-24-000082.txt	Edgar Link	pending
0001587987-24-000082-xbrl.zip	Edgar Link	pending
bsloaneemploymentagreeme.htm	Edgar Link	pending
bsloaneemploymentagreeme001.jpg	Edgar Link	pending
bsloaneemploymentagreeme002.jpg	Edgar Link	pending
bsloaneemploymentagreeme003.jpg	Edgar Link	pending
bsloaneemploymentagreeme004.jpg	Edgar Link	pending
bsloaneemploymentagreeme005.jpg	Edgar Link	pending
bsloaneemploymentagreeme006.jpg	Edgar Link	pending
bsloaneemploymentagreeme007.jpg	Edgar Link	pending
bsloaneemploymentagreeme008.jpg	Edgar Link	pending
bsloaneemploymentagreeme009.jpg	Edgar Link	pending
fdemariaemploymentagreem.htm	Edgar Link	pending
fdemariaemploymentagreem001.jpg	Edgar Link	pending
fdemariaemploymentagreem002.jpg	Edgar Link	pending
fdemariaemploymentagreem003.jpg	Edgar Link	pending
fdemariaemploymentagreem004.jpg	Edgar Link	pending
fdemariaemploymentagreem005.jpg	Edgar Link	pending
fdemariaemploymentagreem006.jpg	Edgar Link	pending
fdemariaemploymentagreem007.jpg	Edgar Link	pending
fdemariaemploymentagreem008.jpg	Edgar Link	pending
fdemariaemploymentagreem009.jpg	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
mschwartzemploymentagree.htm	Edgar Link	pending
mschwartzemploymentagree001.jpg	Edgar Link	pending
mschwartzemploymentagree002.jpg	Edgar Link	pending
mschwartzemploymentagree003.jpg	Edgar Link	pending
mschwartzemploymentagree004.jpg	Edgar Link	pending
mschwartzemploymentagree005.jpg	Edgar Link	pending
mschwartzemploymentagree006.jpg	Edgar Link	pending
mschwartzemploymentagree007.jpg	Edgar Link	pending
mschwartzemploymentagree008.jpg	Edgar Link	pending
mschwartzemploymentagree009.jpg	Edgar Link	pending
newt-20240331.htm	Edgar Link	pending
newt-20240331.xsd	Edgar Link	pending
newt-33124xexh312.htm	Edgar Link	pending
newt-33124xexh321.htm	Edgar Link	pending
newt-33124xexh322.htm	Edgar Link	pending
newt33124-exh311.htm	Edgar Link	pending
nyoungnewtekbankemployme.htm	Edgar Link	pending
nyoungnewtekbankemployme001.jpg	Edgar Link	pending
nyoungnewtekbankemployme002.jpg	Edgar Link	pending
nyoungnewtekbankemployme003.jpg	Edgar Link	pending
nyoungnewtekbankemployme004.jpg	Edgar Link	pending
nyoungnewtekbankemployme005.jpg	Edgar Link	pending
nyoungnewtekbankemployme006.jpg	Edgar Link	pending
nyoungnewtekbankemployme007.jpg	Edgar Link	pending
nyoungnewtekbankemployme008.jpg	Edgar Link	pending
nyoungnewtekbankemployme009.jpg	Edgar Link	pending
nyoungnewtekbankemployme010.jpg	Edgar Link	pending
pdownsemplagmentapril520.htm	Edgar Link	pending
pdownsemplagmentapril520001.jpg	Edgar Link	pending
pdownsemplagmentapril520002.jpg	Edgar Link	pending
pdownsemplagmentapril520003.jpg	Edgar Link	pending
pdownsemplagmentapril520004.jpg	Edgar Link	pending
pdownsemplagmentapril520005.jpg	Edgar Link	pending
pdownsemplagmentapril520006.jpg	Edgar Link	pending
pdownsemplagmentapril520007.jpg	Edgar Link	pending
pdownsemplagmentapril520008.jpg	Edgar Link	pending
pdownsemplagmentapril520009.jpg	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
newt-20240331_cal.xml	Edgar Link	unprocessable
newt-20240331_def.xml	Edgar Link	unprocessable
newt-20240331_lab.xml	Edgar Link	unprocessable
newt-20240331_pre.xml	Edgar Link	unprocessable
newt-20240331_htm.xml	Edgar Link	completed
R100.htm	Edgar Link	pending
R101.htm	Edgar Link	pending
R102.htm	Edgar Link	pending
R103.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$NEWT
NewtekOne, Inc. Stock $newt

2024 Q2 Form 10-Q Financial Statement

#000158798724000082 Filed on May 10, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NEWT NewtekOne, Inc. Stock $newt

2024 Q2 Form 10-Q Financial Statement

#000158798724000082 Filed on May 10, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NEWT
NewtekOne, Inc. Stock $newt